Balyasny Asset Management’s Kindred Healthcare KND Stock Holding History

Balyasny Asset Management’s Portfolio KND Stock Details KND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-17,717	Closed	-$159K	–	2266
2018 Q2	$159K	Buy	+17,717	New	+$159K	﹤0.01%	1667
2018 Q1	–	Sell	-12,200	Closed	-$118K	–	2534
2017 Q4	$118K	Sell	12,200 -200	-2%	-$1.49K	﹤0.01%	1969
2017 Q3	$84K	Buy	+12,400	New	+$106K	﹤0.01%	1794
2016 Q1	–	Sell	-19,740	Closed	-$235K	–	1660
2015 Q4	$235K	Sell	19,740 -2,160	-10%	-$28K	﹤0.01%	1053
2015 Q3	$345K	Buy	21,900 +11,150	+104%	+$226K	﹤0.01%	882
2015 Q2	$218K	Buy	+10,750	New	+$246K	﹤0.01%	1004

Balyasny Asset Management's KND Position: Q3 2018 in Review

Balyasny Asset Management sold out of Kindred Healthcare (KND) in Q3 2018, closing a stake of 17,717 shares — an estimated $159K sold.

Balyasny Asset Management first reported a position in KND in Q2 2015 and held it in 6 quarters. The position peaked at $345K in Q3 2015. 0 funds tracked by Wall St. Rank hold KND as of Q3 2018.

Balyasny Asset Management reported no remaining Kindred Healthcare position as of Q3 2018 after selling out during the quarter.
Balyasny Asset Management sold 17,717 Kindred Healthcare shares in Q3 2018, an estimated $159K.
Balyasny Asset Management first reported a position in Kindred Healthcare in Q2 2015 and held it in 6 quarters.
Balyasny Asset Management's Kindred Healthcare position peaked at $345K in Q3 2015.
0 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.